Search Pages
PrintPrint EmailEmail
Theresa Ryan

Biosketch / Results /

Theresa Ryan, M.D.

Assistant Professor; Assist Program Director, Medical Oncology
Department of Medicine (Residency Program)
NYU Medical Oncology Associates

Clinical Addresses

160 EAST 34TH STREET
NEW YORK, NY 10016
Hours: Tue. 9 - 5; Wed. 9 - 5; Thu. 9 - 5
Handicap Access: yes
Phone: 212-731-5430
Fax: 212-731-6051

« Back to Results

Medical Specialties

Cancer, Medical Oncology

Medical Expertise

Neuroendocrine Tumors, Kidney Cancer, Rectal Cancer, Esophageal Cancer, Colon Cancer, Liver Cancer, Colorectal Cancer, Gastrointestinal Cancers, Gastric (Stomach) Cancer, Pancreatic Cancer, Gallbladder Cancer

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO, AFFINITY, Beech St PPO, Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, GHI CBP, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, MULTIPLAN/PHCS PPO, Medicare, NYS EMPIRE PLAN, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIER

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2003 — Ab Internal Medicine (Medical Oncology)
2003 — Ab Internal Medicine (Hematology)

Education

1996 — New York University School of Medicine, Medical Education
1996-2000 — New York University School of Medicine (Medicine), Residency Training
2000-2003 — New York University School of Medicine (Hematology Oncology), Clinical Fellowships

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Postoperative Intraperitoneal 5-Fluoro-2'-Deoxyuridine Added to Chemoradiation in Patients Curatively Resected (R0) for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
2012 Feb;19(2):478-485, Annals of surgical oncology
— id: 135531, year: 2012, vol: 19, page: 478, stat: Journal Article,

Cisplatin with Capecitabine: Tolerance and Activity in a Phase I/II Study Preferentially Enrolling Patients with Gastric Cancer
Wu, Jennifer; Ryan, Theresa; Levinson, Benjamin; Newman, Elliot; Hochster, Howard S; Muggia, Franco
2012 Mar;32(3):939-945, Anticancer research
— id: 159861, year: 2012, vol: 32, page: 939, stat: Journal Article,

Phase II study of sorafenib with gemcitabine and erlotinib (GES) in first-line advanced pancreatic cancer
Cohen, D J; Leichman, L P; Love, E; Ryan, T; Leichman, C G; Newman, E; Levinson, B; Hochster, H S
2011 01 Feb 2011;29(4):-, Journal of clinical oncology
— id: 161217, year: 2011, vol: 29, page: , stat: Journal Article,

Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma
Wu, Jennifer; Henderson, Charles; Feun, Lynn; Van Veldhuizen, Peter; Gold, Philip; Zheng, Hui; Ryan, Theresa; Blaszkowsky, Lawrence S; Chen, Haobin; Costa, Max; Rosenzweig, Barry; Nierodzik, MaryLynn; Hochster, Howard; Muggia, Franco; Abbadessa, Giovanni; Lewis, Jonathan; Zhu, Andrew X
2010 Oct;28(5):670-676, Investigational new drugs
— id: 138148, year: 2010, vol: 28, page: 670, stat: Journal Article,

Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study
Hochster, Howard; Weller, Edie; Gascoyne, Randy D; Habermann, Thomas M; Gordon, Leo I; Ryan, Theresa; Zhang, Lijun; Colocci, Natalia; Frankel, Stanley; Horning, Sandra J
2009 Apr 1;27(10):1607-1614, Journal of clinical oncology
— id: 97960, year: 2009, vol: 27, page: 1607, stat: Journal Article,

Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally advanced pancreatic cancer
Marti, Jennifer L; Hochster, Howard S; Hiotis, Spiros P; Donahue, Bernadine; Ryan, Theresa; Newman, Elliot
2008 Dec;15(12):3521-3531, Annals of surgical oncology
— id: 93218, year: 2008, vol: 15, page: 3521, stat: Journal Article,

Intraperitoneal(IP) 5'-fluoro-2'deoxyuridine(FUDR): Safety and outcome when administered prior to adjuvant chemoradiotherapy(chemoRT) following R0 resection for gastric adenocarcinoma
Cohen DJ; Ryan T; Newman E; Iqbal S; Liu M; Utate M; Moore S; Potmesil M; Hochster H; Muggia FM
2007 ;25(18S Suppl):4627-4627, Journal of clinical oncology
— id: 75186, year: 2007, vol: 25, page: 4627, stat: Journal Article,

Phase I dose-escalating study of bi-weekly pemetrexed (MTA) with fixed dose rate gemcitabine (gem) in patients with advanced cancer
Chen, AL; Ryan, T; Muggia, F; Chachoua, A; Escalon, J; Moore, S; Haniff, F; Levinson, B; Nicol, S; Hochster, H
2006 JUN 20 ;24(18):91S-91S, Journal of clinical oncology
— id: 69296, year: 2006, vol: 24, page: 91S, stat: Journal Article,

Prognostic significance of the follicular lymphoma international prognostic index (FLIPI) in the E1496 trial of chemotherapy with or without maintenance rituximab
Colocci, N; Weller, E; Hochster, HS; Gascoyne, R; Kumm, B; Ryan, T; Habermann, TM; Frankel, SR; Horning, SJ
2005 JUN 1 ;23(16):566S-566S, Journal of clinical oncology
— id: 57800, year: 2005, vol: 23, page: 566S, stat: Journal Article,

Postoperative intraperitoneal (IP) 5'-fluoro-2'-deoxyuridine (FUDR) added to chemoradiation in patients curatively resected (RO) for locally advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma
Newman, E; Chang, RY; Potmesil, M; Donahue, B; Marcus, SG; Hiotis, SP; Iqbal, S; Ryan, T; Hochster, HS; Muggia, FM
2005 JUN 1 ;23(16):348S-348S, Journal of clinical oncology
— id: 57796, year: 2005, vol: 23, page: 348S, stat: Journal Article,

Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study
Newman, Elliot; Potmesil, Milan; Ryan, Theresa; Marcus, Stuart; Hiotis, Spiros; Yee, Herman; Norwood, Brendan; Wendell, Marc; Muggia, Franco; Hochster, Howard
2005 Dec;32(6 Suppl 9):S97-100, Seminars in oncology
— id: 62748, year: 2005, vol: 32, page: S97, stat: Journal Article,

Results of E1496: A phase III trial of CVP with or without maintenance rituximab in advanced indolent lymphoma (NHL)
Hochster, HS; Weller, E; Ryan, T; Haberman, TM; Gascoyne, R; Frankel, SR; Horning, SJ
2004 JUL 15 ;22(14):558S-558S, Journal of clinical oncology
— id: 48686, year: 2004, vol: 22, page: 558S, stat: Journal Article,